EGFR and lung carcinoma: In addition, numerous lung-cancer-related mutations (e.g., in ALK, EGFR, and pmKRAS) as well as the loss of heterozygosity, microsatellite instability, and gene methylation, are also readily detected in these cfDNA [62,63].